Dan Brounstein on how closed loop Spinal Cord Stimulation has better efficacy at Saluda

Dan Brounstein is Chief Strategy Officer at Saluda Medical where he is using his 15 years of Spinal Chord Stimulator experience to help deliver closed-loop pain relief directly to the spinal cord.

***This podcast is sponsored by Iris Biomedical, check out their Neurotech Startup Services here***

Top 3 Takeaways:

•  "We're stimulating with milliamps and we're trying to measure in microvolts, and we always use the analogy trying to listen to a pin drop next to a shotgun shot"

• "There's a lot of literature on loss of efficacy? It's just a therapy issue. When you deliver open-loop therapies blind across a neural target, you're ultimately going to create, over-stimulation in a lot of times under stimulation. On top of that, over time things change"

• "Patients come in between four and five times a year on average in perpetuity with open loop systems"

0:45 " Do you want to introduce yourself and the company better than I just did?"

6:00 "Your guys' device reprograms on its own? And then what signals does it take in and how does it change the stimulation patterns based on that?"

9:00 Iris Biomedical ad sponsorship

9:45 "What is your input and output for your guys' device?"

11:45 "In February of 2023, you guys got FDA approval for this. Do you wanna talk a little bit about this?"

14:15 "Is it like 5% better than open loop or is that something that's gonna be coming out published later?"

17:00 "Is there another indication?"

18:15 "The last I guess seven years for you has been very exciting. Is there anything on the horizon for the next seven years?"

20:15 "You guys have 300 people and have raised 200 million. What's it like working in such a big company"

22:45 "Is it getting too big for you?"

23:45 "What advice do you have for people in your situation?"

26:00 "Is there anything that we didn't talk about that you wanted to mention?"